Category: VIGILANCE GUIDANCE DOCUMENTSPDF: Trend in ABO-incompatible RBC transfusion-related fatalities reported to the FDA, 2000-2019 Revised Recommendations for Reducing the Risk of HIV Transmission by Blood and Blood Products Recommendations to Reduce Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant CJ by blood - August 2020 Revised Recommendations Reducing Risk HIV Transmission by blood and blood components - April 2020 Revised Recommendations Reducing Risk Transfusion Transmitted Malaria - April 2020 FDA Investigating and reporting adverse reactions - Guidance for Industry
